Financhill
Back

Novo Nordisk A/S Quote, Financials, Valuation and Earnings

New AI Stock Payouts

Watch this presentation before then!
Buy
65

NVO
Novo Nordisk A/S

Last Price:
124.25
Seasonality Move:
3.37%

7 Day Trial

ALL ACCESS PASS

$ 7

The "Scaled Selling Technique"

Click here for more details...

Novo Nordisk A/S Price Quote

$124.25
+0.02 (+3.74%)
(Updated: March 2, 2024 at 8:37 AM ET)

Novo Nordisk A/S Key Stats

Buy
65
Novo Nordisk A/S (NVO) is a Buy

Day range:
$122.25 - $124.43
52-week range:
$67.66 - $124.87
Dividend yield:
0.83%
P/E ratio:
45.95
P/S ratio:
16.56
P/B ratio:
35.04%

Volume:
5.4M
Avg. volume:
5.3M
1-year change:
73.92%
Market cap:
$554.4B
Revenue:
$33.7B
EPS:
$2.7

How Much Does Novo Nordisk A/S Make?

Is Novo Nordisk A/S Growing As A Company?

  • What Is Novo Nordisk A/S's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.44%
  • What Is Novo Nordisk A/S's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.71%

Novo Nordisk A/S Stock Price Performance

  • Did Novo Nordisk A/S Stock Go Up Last Month?
    Novo Nordisk A/S share price went up by 7.29% last month
  • Did NVO's Share Price Rise Over The Last Year?
    NVO share price rose by 73.92% over the past 1 year

What Is Novo Nordisk A/S 52-Week High & Low?

Novo Nordisk A/S Price To Free Cash Flow

Is It Risky To Buy Novo Nordisk A/S?

  • How Much Debt Does Novo Nordisk A/S Have?
    Total long term debt quarterly is $3.2B
  • How Much Cash Does Novo Nordisk A/S Have?
    Cash and short term investments quarterly total is $4.5B
  • What Is Novo Nordisk A/S’s Book Value Per Share?
    Book value per share is 3.55

Is Novo Nordisk A/S Cash Flow Positive?

  • What Is NVO Cash Flow From Operations?
    Cash flow from operations (TTM) is $15.8B
  • What Is Novo Nordisk A/S’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$9.2B
  • What Is Novo Nordisk A/S’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$6.4B

Novo Nordisk A/S Return On Invested Capital

  • Is Management Doing A Good Job?
    NVO return on invested capital is 72.87%
  • What Is Novo Nordisk A/S Return On Assets?
    ROA measures how assets are converting to revenues and is 30.15%
  • What Is NVO Return On Equity?
    ROE is a measure of profitability and is 92.18%

Novo Nordisk A/S Earnings Date & Stock Price

Novo Nordisk A/S Competitors

  • Who Are Novo Nordisk A/S's Competitors?
    Below is a list of companies who compete with Novo Nordisk A/S or are related in some way:
    • CytomX Therapeutics Inc (CTMX)
    • Regeneron Pharmaceuticals Inc (REGN)
    • Sarepta Therapeutics Inc (SRPT)
    • Viking Therapeutics Inc (VKTX)
    • Vertex Pharmaceuticals Inc (VRTX)

Novo Nordisk A/S Dividend Yield

Novo Nordisk A/S Analyst Estimates

YoY Growth Past Surprise
EPS: 71.25% 9.34%
Revenue: 43.78% 7.57%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 124.43
Upside from Last Price: 0.16%

Major Shareholders

  • How many NVO shares are owned by institutional investors?
    372.3M NVO shares are owned by institutional investors
  • How many NVO shares are owned by insiders?
    0 NVO shares are owned by insiders